The global Bevacizumab market size was valued at US$ 6.78 billion in 2024 and is projected to reach US$ 8.91 billion by 2030, at a CAGR of 4.7% during the forecast period 2024-2030.
United States Bevacizumab market size was valued at US$ 2.21 billion in 2024 and is projected to reach US$ 2.79 billion by 2030, at a CAGR of 4.0% during the forecast period 2024-2030.
Monoclonal antibody used to treat various types of cancer.
Growing demand due to expanding cancer indications and combination therapies. Biosimilar competition impacting market dynamics in some regions. Ongoing clinical trials for new indications supporting market growth.
Report Overview
Bevacizumab, sold under the trade name Avastin, is a medication used to treat a number of types of cancers and a specific eye disease.
This report provides a deep insight into the global Bevacizumab market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Bevacizumab Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Bevacizumab market in any manner.
Global Bevacizumab Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Genentech
Amgen
Market Segmentation (by Type)
Avastin (bevacizumab)
Mvasi (bevacizumab-awwb)
Market Segmentation (by Application)
Cancer
Eye Diease
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Bevacizumab Market
Overview of the regional outlook of the Bevacizumab Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Bevacizumab
1.2 Key Market Segments
1.2.1 Bevacizumab Segment by Type
1.2.2 Bevacizumab Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Bevacizumab Market Overview
2.1 Global Market Overview
2.1.1 Global Bevacizumab Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Bevacizumab Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Bevacizumab Market Competitive Landscape
3.1 Global Bevacizumab Sales by Manufacturers (2019-2024)
3.2 Global Bevacizumab Revenue Market Share by Manufacturers (2019-2024)
3.3 Bevacizumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Bevacizumab Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Bevacizumab Sales Sites, Area Served, Product Type
3.6 Bevacizumab Market Competitive Situation and Trends
3.6.1 Bevacizumab Market Concentration Rate
3.6.2 Global 5 and 10 Largest Bevacizumab Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Bevacizumab Industry Chain Analysis
4.1 Bevacizumab Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Bevacizumab Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Bevacizumab Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Bevacizumab Sales Market Share by Type (2019-2024)
6.3 Global Bevacizumab Market Size Market Share by Type (2019-2024)
6.4 Global Bevacizumab Price by Type (2019-2024)
7 Bevacizumab Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Bevacizumab Market Sales by Application (2019-2024)
7.3 Global Bevacizumab Market Size (M USD) by Application (2019-2024)
7.4 Global Bevacizumab Sales Growth Rate by Application (2019-2024)
8 Bevacizumab Market Segmentation by Region
8.1 Global Bevacizumab Sales by Region
8.1.1 Global Bevacizumab Sales by Region
8.1.2 Global Bevacizumab Sales Market Share by Region
8.2 North America
8.2.1 North America Bevacizumab Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Bevacizumab Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Bevacizumab Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Bevacizumab Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Bevacizumab Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Genentech
9.1.1 Genentech Bevacizumab Basic Information
9.1.2 Genentech Bevacizumab Product Overview
9.1.3 Genentech Bevacizumab Product Market Performance
9.1.4 Genentech Business Overview
9.1.5 Genentech Bevacizumab SWOT Analysis
9.1.6 Genentech Recent Developments
9.2 Amgen
9.2.1 Amgen Bevacizumab Basic Information
9.2.2 Amgen Bevacizumab Product Overview
9.2.3 Amgen Bevacizumab Product Market Performance
9.2.4 Amgen Business Overview
9.2.5 Amgen Bevacizumab SWOT Analysis
9.2.6 Amgen Recent Developments
10 Bevacizumab Market Forecast by Region
10.1 Global Bevacizumab Market Size Forecast
10.2 Global Bevacizumab Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Bevacizumab Market Size Forecast by Country
10.2.3 Asia Pacific Bevacizumab Market Size Forecast by Region
10.2.4 South America Bevacizumab Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Bevacizumab by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Bevacizumab Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Bevacizumab by Type (2025-2030)
11.1.2 Global Bevacizumab Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Bevacizumab by Type (2025-2030)
11.2 Global Bevacizumab Market Forecast by Application (2025-2030)
11.2.1 Global Bevacizumab Sales (Kilotons) Forecast by Application
11.2.2 Global Bevacizumab Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Bevacizumab Market Size Comparison by Region (M USD)
Table 5. Global Bevacizumab Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Bevacizumab Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Bevacizumab Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Bevacizumab Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bevacizumab as of 2022)
Table 10. Global Market Bevacizumab Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Bevacizumab Sales Sites and Area Served
Table 12. Manufacturers Bevacizumab Product Type
Table 13. Global Bevacizumab Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Bevacizumab
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Bevacizumab Market Challenges
Table 22. Global Bevacizumab Sales by Type (Kilotons)
Table 23. Global Bevacizumab Market Size by Type (M USD)
Table 24. Global Bevacizumab Sales (Kilotons) by Type (2019-2024)
Table 25. Global Bevacizumab Sales Market Share by Type (2019-2024)
Table 26. Global Bevacizumab Market Size (M USD) by Type (2019-2024)
Table 27. Global Bevacizumab Market Size Share by Type (2019-2024)
Table 28. Global Bevacizumab Price (USD/Ton) by Type (2019-2024)
Table 29. Global Bevacizumab Sales (Kilotons) by Application
Table 30. Global Bevacizumab Market Size by Application
Table 31. Global Bevacizumab Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Bevacizumab Sales Market Share by Application (2019-2024)
Table 33. Global Bevacizumab Sales by Application (2019-2024) & (M USD)
Table 34. Global Bevacizumab Market Share by Application (2019-2024)
Table 35. Global Bevacizumab Sales Growth Rate by Application (2019-2024)
Table 36. Global Bevacizumab Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Bevacizumab Sales Market Share by Region (2019-2024)
Table 38. North America Bevacizumab Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Bevacizumab Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Bevacizumab Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Bevacizumab Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Bevacizumab Sales by Region (2019-2024) & (Kilotons)
Table 43. Genentech Bevacizumab Basic Information
Table 44. Genentech Bevacizumab Product Overview
Table 45. Genentech Bevacizumab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Genentech Business Overview
Table 47. Genentech Bevacizumab SWOT Analysis
Table 48. Genentech Recent Developments
Table 49. Amgen Bevacizumab Basic Information
Table 50. Amgen Bevacizumab Product Overview
Table 51. Amgen Bevacizumab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Amgen Business Overview
Table 53. Amgen Bevacizumab SWOT Analysis
Table 54. Amgen Recent Developments
Table 55. Global Bevacizumab Sales Forecast by Region (2025-2030) & (Kilotons)
Table 56. Global Bevacizumab Market Size Forecast by Region (2025-2030) & (M USD)
Table 57. North America Bevacizumab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 58. North America Bevacizumab Market Size Forecast by Country (2025-2030) & (M USD)
Table 59. Europe Bevacizumab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 60. Europe Bevacizumab Market Size Forecast by Country (2025-2030) & (M USD)
Table 61. Asia Pacific Bevacizumab Sales Forecast by Region (2025-2030) & (Kilotons)
Table 62. Asia Pacific Bevacizumab Market Size Forecast by Region (2025-2030) & (M USD)
Table 63. South America Bevacizumab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 64. South America Bevacizumab Market Size Forecast by Country (2025-2030) & (M USD)
Table 65. Middle East and Africa Bevacizumab Consumption Forecast by Country (2025-2030) & (Units)
Table 66. Middle East and Africa Bevacizumab Market Size Forecast by Country (2025-2030) & (M USD)
Table 67. Global Bevacizumab Sales Forecast by Type (2025-2030) & (Kilotons)
Table 68. Global Bevacizumab Market Size Forecast by Type (2025-2030) & (M USD)
Table 69. Global Bevacizumab Price Forecast by Type (2025-2030) & (USD/Ton)
Table 70. Global Bevacizumab Sales (Kilotons) Forecast by Application (2025-2030)
Table 71. Global Bevacizumab Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Bevacizumab
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Bevacizumab Market Size (M USD), 2019-2030
Figure 5. Global Bevacizumab Market Size (M USD) (2019-2030)
Figure 6. Global Bevacizumab Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Bevacizumab Market Size by Country (M USD)
Figure 11. Bevacizumab Sales Share by Manufacturers in 2023
Figure 12. Global Bevacizumab Revenue Share by Manufacturers in 2023
Figure 13. Bevacizumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Bevacizumab Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Bevacizumab Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Bevacizumab Market Share by Type
Figure 18. Sales Market Share of Bevacizumab by Type (2019-2024)
Figure 19. Sales Market Share of Bevacizumab by Type in 2023
Figure 20. Market Size Share of Bevacizumab by Type (2019-2024)
Figure 21. Market Size Market Share of Bevacizumab by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Bevacizumab Market Share by Application
Figure 24. Global Bevacizumab Sales Market Share by Application (2019-2024)
Figure 25. Global Bevacizumab Sales Market Share by Application in 2023
Figure 26. Global Bevacizumab Market Share by Application (2019-2024)
Figure 27. Global Bevacizumab Market Share by Application in 2023
Figure 28. Global Bevacizumab Sales Growth Rate by Application (2019-2024)
Figure 29. Global Bevacizumab Sales Market Share by Region (2019-2024)
Figure 30. North America Bevacizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Bevacizumab Sales Market Share by Country in 2023
Figure 32. U.S. Bevacizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Bevacizumab Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Bevacizumab Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Bevacizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Bevacizumab Sales Market Share by Country in 2023
Figure 37. Germany Bevacizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Bevacizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Bevacizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Bevacizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Bevacizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Bevacizumab Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Bevacizumab Sales Market Share by Region in 2023
Figure 44. China Bevacizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Bevacizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Bevacizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Bevacizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Bevacizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Bevacizumab Sales and Growth Rate (Kilotons)
Figure 50. South America Bevacizumab Sales Market Share by Country in 2023
Figure 51. Brazil Bevacizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Bevacizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Bevacizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Bevacizumab Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Bevacizumab Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Bevacizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Bevacizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Bevacizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Bevacizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Bevacizumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Bevacizumab Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Bevacizumab Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Bevacizumab Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Bevacizumab Market Share Forecast by Type (2025-2030)
Figure 65. Global Bevacizumab Sales Forecast by Application (2025-2030)
Figure 66. Global Bevacizumab Market Share Forecast by Application (2025-2030)
